Frasor J, Danes J M, Komm B, et al. Profiling of estrogen up- and down-regulated gene networks and pathways underlying estrogenic control of proliferation and cell phenotype[J]. Endocrinology, 2003, 144: 4562-4574.杨清旭 , 谢铭 . 雌激素膜受体 GPR30 在雌激素相关性肿瘤中的研究进展 [J]. 医学综述 , 2020, 26(6): 1078-1085.Revankar C M, Cimino D F, Sklar L A. A transmembrane intracellular estrogen receptor mediates rapid cell signaling[J]. Science, 2005, 307(5715): 1625-1630.巩月红, 冯晓辉, 高晓黎, 等. 雌酮人工抗原的制备与鉴定 [J].医药导报 , 2010, 29(7): 923-925.Yaghjyan L, Graham A C. Estrogens in the breast tissue: a systematic review[J]. Cancer Causes Control, 2011, 22: 529-540.Ebling F J, Brooks A N, Cronin A S, et al. Estrogenic induction of spermatogenesis in the hypogonadal mouse[J]. Endocrinology, 2000, 141(8): 2861-2869.詹晓庆 , 王鲜忠 , 张家骅 . 雌激素受体和雌性生殖研究进展 [J].动物医学进展 , 2005, 26: 35-39.Eick G N, Thornton J W. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor[J]. Mol Cell Endocrinol, 2011, 334: 31-38.Greene G L, Gilna P, Waterfield M, et al. Sequence and expression of human estrogen receptor complementary DNA[J]. Science, 1986, 231(4742): 1150-1154.Kuiper G G, Enmark E, Pelto-Huikko M, et al. Cloning of a novel receptor expressed in rat prostate and ovary[J]. Proc Natl Acad Sci USA, 1996, 93: 5925-5930.Stashi E, York B, O’Malley B W. Steroid receptor coactivators: servants and masters for control of systems metabolism[J]. Trends Endocrinol Metab, 2014, 25(1): 337-347.Lee H R, Kim T H, Choi K C. Functions and physiological roles of two types of estrogen receptors, ERα and ERβ, identified by estrogen receptor knockout mouse[J]. Lab Anim Res, 2012, 28: 71-76.Cirillo F, Nassa G, Tarallo R, et al. Molecular mechanisms of selective estrogen receptor modulator activity in human breast cancer cells: identification of novel nuclear cofactors of antiestrogen-ER alpha complexes by interaction prote-omics[J]. J Proteome Res, 2013, 12(1): 421-431.Otto C, Rohde-Schulz B, Schwarz G, et al. G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol[J]. Endocrinology, 2008, 149(10): 4846-4856.Albanito L, Sisci D, Aquila S, et al. Epidermal growth factor induces G protein-coupled receptor 30 expression in estrogen receptor-negative breast cancer cells[J]. Endocrinology, 2008, 149: 3799-3808.Toran-Allerand C, Dominique, Guan Xiaoping, et al. ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury[J]. J Neurosci, 2002, 22(19): 8391-8401.Qiu J, Ronnekleiv O K, Kelly M J. Modulation of hypothalamic neuronal activity through a novel G-protein-coupled estrogen membrane receptor[J]. Steroids, 2008, 73: 985-991.梅春霞 , 张吉强 . 雌激素受体 [J]. 生命的化学 , 2010, 30(4): 590-594.McDonnell D P, Norris J D. Connections and regulation of the human estrogen receptor[J]. Science, 2002, 296: 1642-1644.Habauzit D, Bayle S, Benimelis D, et al. Impact of biochemical design on estrogen receptor/estrogen response element interaction by surface plasmon resonance technology[J]. Arch Biochem Biophys, 2014, 541: 61-66.Safe S. Transcriptional activation of genes by 17 beta-estradiol through estrogen receptor Sp1 interactions[J]. Vitam Horm, 2001, 62: 231-252.Karin D W, Qiao Y, Philip J, et al. Interplay between AP-1 and estrogen receptor α in regulating gene expression and proliferation networks in breast cancer cells[J]. Carcinogenesis, 2012, 33(9): 1684-1691.Harnish D C, Scicchitano M S, Adelman S J, et al. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells[J]. Endocrinology, 2000, 141: 3403-3411.Bunone G, Briand P A, Miksicek R J, et al. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation[J]. EMBO J, 1996, 15: 2174- 2183.Cerillo G, Rees A, Manchanda N, et al. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner[J]. J Steroid Biochem Mol Biol, 1998, 67(2): 79-88.Maret A, Clamens S, Delrieu I, et al. Expression of the interleukin-6 gene is constitutive and not regulated by estrogen in rat vascular smooth muscle cells in culture[J]. Endocrinology, 1999, 140: 2876- 2882.Driggers P H, Segars J H. Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling[J]. Trends Endocrinol Metab, 2002, 13(10): 422- 427.Eyster K M. The estrogen receptors: an overview from different perspectives[J]. Methods Mol Biol, 2016, 1366: 1-10.Song R X, Mcpherson R A, Adam L, et al. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation[J]. Mol Endocrinol, 2002, 16(1): 116-127.Quinn J A , Graeber C T, Frackelton A R, et al. Coordinate regulation of estrogen-mediated fibronectin matrix assembly and epidermal growth factor receptor transactivation by the G protein- coupled receptor, GPR30[J]. Mol Endocrinol, 2009, 23(7): 1052- 1064.Broselid S, Berg K A, Chavera T A, et al. G protein-coupled receptor 30 (GPR30) forms a plasma membrane complex with membrane-associated guanylate kinases (MAGUKs) and protein kinase A anchoring protein 5 (AKAP5) that constitutively inhibits cAMP production[J]. J Biol Chem, 2014, 289(32): 117-127.Lappano R, Rigiracciolo D, Marco P D, et al. Recent advances on the role of G protein-coupled receptors in hypoxia-mediated signaling[J]. AAPS J, 2016, 18(2): 305-310.Huang B, Omoto Y, Iwase H, et al. Differential expression of estrogen receptor alpha, beta1, and beta2 in lobular and ductal breast cancer[J]. Proc Natl Acad Sci USA, 2014, 111(5): 1933-1938.Zhang X T, Kang L G, Ding L, et al. A positive feedback loop of ER-alpha36/EGFR promotes malignant growth of ER-negative breast cancer cells[J]. Oncogene, 2011, 30(7): 770-780.Tanimoto K, Eguchi H, Yoshida T, et al. Regulation of estrogen receptor alpha gene mediated by promoter B responsible for its enhanced expression in human breast cancer[J]. Nucleic Acids Res, 1999, 27(3): 903-909.Yoshida T, Eguchi H, Nakachi K, et al. Distinct mechanisms of loss of estrogen receptor α gene expression in human breast cancer methylation of the gene and alteration of transacting factor[J]. Carcinogenesis, 2000, 12: 2193-2201.Jensen E V, Cheng G, Palmieri C, et al. Estrogen receptors and proliferation markers in primary and recurrent breast cancer[J]. Proc Natl Acad Sci USA, 2001, 26: 15197-15202.Mann S, Laucirica R, Carlson N, et al. Estrogen receptor β expression in invasive breast cancer[J]. Hum Pathol, 2001, 32: 113- 118.Wei W, Chen Z J, Zhang K S, et al. The activation of G protein- coupled receptor 30 (GPR30) inhibits proliferation of estrogen receptor-negative breast cancer cells in vitro and in vivo[J]. Cell Death Dis, 2014, 5(10): 398-410.Girgert R, Emons G, Gründker C. 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib[J]. Oncol Rep, 2017, 37(2): 1212-1218.Marjon N A, Hu C, Hathaway H J, et al. G protein-coupled estrogen receptor (GPER) regulates mammary tumorigenesis and metastasis[J]. Mol Cancer Res, 2014, 12(11): 1644-1654.Mirkin S, Pickar J H. Selective estrogen receptor modulators (SERMs): a review of clinical data[J]. Maturitas, 2015, 80(1): 52-57.吉庆刚, 谢毓元. 选择性雌激素受体调节剂的研究与开发 [J].药学进展 , 2005, 29(8): 344-349.Pickar J H, Komm B S. Selective estrogen receptor modulators and the combination therapy conjugated estrogens/bazedoxifene: a review of effects on the breast[J]. Post Reprod Health, 2015, 21(3): 112-121.Wakeling A E. Similarities and distinctions in the mode of action of different classes of antioestrogens[J]. Endocr Relat Cancer, 2000, 7(1): 17-28.Pyrhnen S, Valavaara R, Vuorinen J, et al. High dose toremifene in advanced breast cancer resistant to or relapsed during tamoxifen treatment[J]. Breast Cancer Res Treat, 1994, 29(3): 223-228.Milla-Santos A, Milla L, Rallo L, et al. Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer[J]. Breast Cancer Res Treat, 2001, 65(2): 119-124.Stovall D W, Pinkerton J V. Estrogen agonists/antagonists in combination with estrogen for prevention and treatment of menopause-associated signs and symptoms[J]. Womens Health (Lond), 2008, 4(3): 257-268.Simard J, Sanchez R, Poirier D, et al. Blockade of the stimulatory effect of estrogens, OH-tamoxifen, OH-toremifene, droloxifene, and raloxifene on alkaline phosphatase activity by the antiestrogen EM-800 in human endometrial adenocarcinoma Ishikawa cells[J]. Cancer Res, 1997, 57(16): 3494-3497.Musa A M, Cooperwood J S, Khan M O, et al. A review of coumarin derivatives in pharmacotherapy of breast cancer[J]. Curr Med Chem, 2008, 1(15): 2664-2679.Draper M W. SERMs: how do they work?[J]. Eur J Cancer, 2002, 38: 35. Doi: 10.1016/S0959-8049(02)00278-2.Powell E, Huang S X, Xu Y, et al. Identification and characterization of a novel estrogenic ligand actinopolymorphol A[J]. Biochem Pharmacol, 2010, 80(8): 1221-1229.Musa M A, Cooperwood J S, Khan M O. A review of coumarin derivatives in pharmacotherapy of breast cancer[J]. Curr Med Chem, 2008, 15(26): 2664-2679.Santner S J, Feil P D, Santen R J. In situ estrogen production via the estrone sulfatase pathway in breast tumors: relative importance versus the aromatase pathway[J]. J Clin Endocrinol Metab, 1984, 59(1): 29-33.